StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ITX.L$125.00+8.70%
Fair $125.00+0.0%

ITX.L

Itaconix plc

Basic Materials / Specialty ChemicalsLSE

$125.00

+10.00 (+8.70%)

Fairly Valued+0.0%Fair Value $125.00Fund rank 32/100 · Data gapFallback financials|
SA 42/C
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $-2.2M · quality 69.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 35/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -16.8%, below the 5% threshold
Thesis & Journal · ITX.LLocal privado en este navegador · Itaconix plc
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$17M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-16.8%

↓

Gross Margin

34.7%

↑

Debt/Equity

0.25

↑
52-Week Range$125
$95$142

TradingView lightweight chart

ITX.L price, volumen y niveles de valoración

Último $125.00Periodo -96.6%
Fair value: $125.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+23.3%

FCF CAGR

—

FCF margin

-19.6%

FCF / Net income

1.49x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.5M · net income $-1.4M · FCF $-2.1M

2022-FY → 2025-FY

Gross margin

34.7%+8.1% pts

Operating margin

-9.9%+31.5% pts

Net margin

-13.1%+30.8% pts

FCF margin

-19.6%-14.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$10.5M$10.5M$6.5M$7.9M$5.6M
Net Income$-1.4M$-1.4M$-2.0M$-1.5M$-2.5M
EBITDA$-827000.00$-827000.00$-1.5M$-1.0M$-2.0M
EPS-0.10-0.10-0.14-0.12-0.25
Gross Margin34.7%34.7%34.8%31.0%26.6%
Operating Margin-9.9%-9.9%-33.6%-19.7%-41.4%
Net Margin-13.1%-13.1%-31.1%-19.5%-44.0%
Balance Sheet
Debt/Equity0.250.250.230.20-0.39
Current Ratio3.423.42———
Cash Flow
Free Cash Flow$-2.1M$-2.1M$-3.3M$-2.2M$-278000.00
Returns
ROE-16.8%-16.8%-22.0%-13.7%317.8%
Valuation
P/B204.73204.73240.30136.38—
Growth & Yield
Revenue Growth61.4%61.4%-17.3%40.5%—
EPS Growth26.1%26.1%-16.0%52.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +25.0%

Total return

+25.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.14 → -0.10

Residual

+25.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+25.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.